Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Research Letters
Open Access

Outcomes of Patients on Maintenance Dialysis Hospitalized with COVID-19

Lili Chan, Suraj K. Jaladanki, Sulaiman Somani, Ishan Paranjpe, Arvind Kumar, Shan Zhao, Lewis Kaufman, Staci Leisman, Shuchita Sharma, John Cijiang He, Barbara Murphy, Zahi A. Fayad, Matthew A. Levin, Erwin P. Bottinger, Alexander W. Charney, Benjamin S. Glicksberg, Steven G. Coca, Girish N. Nadkarni and on behalf of the Mount Sinai COVID Informatics Center (MSCIC)
CJASN March 2021, 16 (3) 452-455; DOI: https://doi.org/10.2215/CJN.12360720
Lili Chan
1Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
2Department of Genetics and Genomics, The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
3Department of Genetics and Genomics, Bio Phenomics Center, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suraj K. Jaladanki
1Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
4The Hasso Plattner Institute for Digital Health at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Suraj K. Jaladanki
Sulaiman Somani
4The Hasso Plattner Institute for Digital Health at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ishan Paranjpe
4The Hasso Plattner Institute for Digital Health at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arvind Kumar
4The Hasso Plattner Institute for Digital Health at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arvind Kumar
Shan Zhao
4The Hasso Plattner Institute for Digital Health at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lewis Kaufman
1Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Staci Leisman
1Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuchita Sharma
1Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Cijiang He
1Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Murphy
1Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zahi A. Fayad
5BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York
6Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew A. Levin
7Department of Anesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
8Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erwin P. Bottinger
4The Hasso Plattner Institute for Digital Health at Mount Sinai, New York, New York
9Department of Genetics and Genomics, Digital Health Center, Hasso Plattner Institute, University of Potsdam, Potsdam, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander W. Charney
8Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York
10The Pamela Sklar Division of Psychiatric Genomics, Icahn School of Medicine at Mount Sinai, New York, New York
11Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin S. Glicksberg
4The Hasso Plattner Institute for Digital Health at Mount Sinai, New York, New York
8Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Benjamin S. Glicksberg
Steven G. Coca
1Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
2Department of Genetics and Genomics, The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Steven G. Coca
Girish N. Nadkarni
1Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
2Department of Genetics and Genomics, The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
3Department of Genetics and Genomics, Bio Phenomics Center, Icahn School of Medicine at Mount Sinai, New York, New York
4The Hasso Plattner Institute for Digital Health at Mount Sinai, New York, New York
8Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading
  • chronic dialysis
  • COVID-19
  • end-stage kidney disease

Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had devastating effects worldwide. Patients with kidney failure on dialysis may have a higher risk of worse outcomes. Reports from China found that these patients with SARS-CoV-2 had fewer symptoms and required less intensive care than expected (1). A recent observational study of hospitalized patients with kidney failure and COVID-19 reported 31% mortality (2). However, this study lacked a comparator group, and thus, it is unclear if this high mortality would be found in patients without kidney failure with a similarly high comorbidity burden. Therefore, we conducted this retrospective cohort study of patients with kidney failure hospitalized with COVID-19 in the Mount Sinai Health Care System (MSHS) and compared it with a propensity-matched cohort without kidney failure.

Only patients age ≥18 years admitted between March 15 and June 7, 2020, with laboratory-confirmed SARS-CoV-2 within 48 hours of admission were included. Patients with kidney failure were identified by a combination of kidney failure diagnosis and dialysis procedure International Classificaton of Diseases codes. Patients with previous kidney transplants were not excluded if they had kidney failure at the time of study. The Mount Sinai Institutional Review Board approved this research.

We propensity matched patients with kidney failure to those without kidney failure (1:5) without use of a caliper by age, sex, race/ethnicity, comorbidities (atrial fibrillation, coronary artery disease, cancer, congestive heart failure, diabetes, hypertension, chronic obstructive pulmonary disease, asthma, peripheral vascular disease, stroke, and liver disease), body mass index (kilograms per meter2), admission facility, and admission week using nearest neighbor matching. Despite propensity matching, significant differences in patient characteristics remained between kidney failure and non-kidney failure cohorts. Therefore, we performed logistic regression analysis after controlling for age, diabetes, hypertension, stroke, coronary artery disease, and congestive heart failure to determine the association between kidney failure and mechanical ventilation, intensive care unit (ICU) admission, and mortality. All analyses were performed using R 4.0.0 (R Foundation, Vienna, Austria).

In total, 122 patients with kidney failure were admitted at MSHS with COVID-19 and matched to 610 patients without kidney failure with COVID-19 from a total of 3270 patients without kidney failure. Patients with kidney failure had a higher prevalence of diabetes (55% versus 43%, P=0.02) and hypertension (66% versus 55%, P=0.03). There were no significant differences in admission symptoms between patients with kidney failure and patients without kidney failure. Patients with kidney failure had higher systolic BP, lower heart rates, and higher oxygen saturation at admission. Patients with kidney failure had lower white blood cell counts (5.5 versus 7.1 103/μl, P<0.001) and higher inflammatory markers of ferritin (3174 versus 1041 ng/ml, P<0.001), erythrocyte sedimentation rate (84 versus 64 mm/h, P=0.001), and procalcitonin (3.4 versus 0.3 ng/ml, P<0.001) (Table 1).

View this table:
  • View inline
  • View popup
Table 1.

Clinical characteristics of patients admitted with coronavirus disease 2019

Patients with kidney failure were less likely to receive mechanical ventilation (11% versus 17%, P=0.11) or be admitted to the ICU (9% versus 21%, P=0.003) and had similar in-hospital mortality (9% versus 12%, P=0.31). There was no difference in do not resuscitate/intubate orders (16% in patients with kidney failure versus 17% in patients without kidney failure, P=0.70). After further adjustments, kidney failure status was associated with lower odds of ICU admission (adjusted odds ratio [aOR], 0.37; 95% confidence interval [95% CI], 0.19 to 0.71), with similar direction of association for mechanical ventilation (aOR, 0.6; 95% CI, 0.32 to 1.11) and mortality (aOR, 0.67; 95% CI, 0.33 to 1.38).

Patients with kidney failure have the highest hospital admission rates out of all Medicare beneficiaries. In this propensity-matched study, we found that although patients with kidney failure had higher comorbidity burden and higher inflammatory markers than patients without kidney failure, there were no significant differences in presenting symptoms and vital signs between patients with kidney failure and patients without kidney failure. Additionally, need for intensive care was lower in patients with kidney failure, and there was no difference in mechanical ventilation or in-hospital mortality.

We report lower in-hospital mortality of patients with kidney failure than other institutions (27%–32%) (2(⇓–4). This is likely due to differences in baseline characteristics; patients with kidney failure who were admitted to MSHS had less diabetes and hypertension than other studies. Additionally, our study time had a longer follow-up period (3 months versus 1 month), and patients who were admitted later in the course of the pandemic may have received different treatments than patients who were admitted earlier.

We found no statistically significant difference in in-hospital mortality between patients with kidney failure and propensity-matched patients without kidney failure who were matched on age and comorbidities. Additionally, there has been speculation that uremia-associated immune dysfunction may blunt the COVID-19 cytokine storm; however, this remains to be proven.

Despite propensity matching, patients with kidney failure had more comorbidities and higher inflammatory markers of ferritin and procalcitonin, but they had lower odds of ICU transfer and similar risk for mechanical ventilation. This is in contrast to previous literature that documents the association of kidney failure status with adverse outcomes (5). Patients with kidney failure had a less severe COVID-19 phenotype with lower heart rate, lower white blood cell count, and higher oxygen saturation than patients without kidney failure. Differences in mechanical ventilation and ICU transfer were unlikely to be driven by code status differences given that the proportion of patients with do not resuscitate/do not intubate status was similar.

Limitations include lack of data on the proportion of patients with kidney failure and COVID-19 who died out of hospital. Additionally, not all patients had inflammatory markers. Also, the use of propensity scores has inherent drawbacks, including the inability to adjust for unmeasured variables such as smoking status, which may bias patient selection and subsequent outcomes.

In conclusion, this is the first study to compare in-hospital outcomes for COVID-19 in patients with kidney failure and matched patients without kidney failure. Although patients with kidney failure had higher inflammatory markers and higher comorbidity burden versus patients without, they had lower odds of mechanical ventilation and similar odds of intensive care use and in-hospital mortality.

Disclosures

E.P. Bottinger reports consultancy agreements with Deloitte and Roland Berger; ownership interest in Digital Medicine E.Böttinger GmbH, EBCW GmbH, and Ontomics, Inc.; receiving honoraria from Bayer, Bosch Health Campus, Sanofi, and Siemens; and serving as a scientific advisor or member of Bosch Health Campus and Seer Biosciences Inc. L. Chan reports receiving research funding from the National Institutes of Health (R01AG066471) and consulting fees from GLG consulting, outside the submitted work. S.G. Coca reports employment with Icahn School of Medicine at Mount Sinai (Mount Sinai owns part of Renalytix AI); consultancy agreements with Akebia, Bayer, Boehringer Ingelheim, CHF Solutions, Goldfinch Bio, inRegen, Quark, Relypsa, Renalytix AI, and Takeda; ownership interest in pulseData and Renalytix AI; receiving research funding from inRegen and Renalytix AI; patents and inventions with Renalytix AI; serving as a scientific advisor or member of Renalytix AI; and serving as an associate editor for Kidney360 and on the editorial board for JASN, CJASN, and Kidney International. S.G. Coca is supported by the following grants: U01DK106962, R01DK115562, R01HL085757, U01OH011326, R01DK112258, and RRTI UG 2019. Z.A. Fayad reports consultancy agreements and ownership interest in Trained Therapeutix Discovery; receiving research funding from the National Institutes of Health; patents and inventions with Trained Therapeutix Discovery; and serving as a scientific advisor or member of Trained Therapeutix Discovery. J. He reports consultancy agreements and ownership interest in Renalytix AI; receiving research funding from Shangpharma Innovation; receiving honoraria from Otsuka; and serving as a scientific advisor or member of the editorial board for Kidney International and JASN, a board member of the Chinese American Society of Nephrology and the International Chinese Society of Nephrology, an associate editor for Kidney Disease, and a section editor for Nephron. B. Murphy reports consultancy agreements with Regeneron and Renalytix AI; ownership interest in Renalytix AI; receiving research funding from the National Institutes of Health; patents and inventions with Fractal Dx; serving on the advisory board for ITBmed, as a board member of Renalytix AI, on the scientific advisory board for Veloxis, and on the advisory board for Vertex; and other interests/relationships with DSMBHansa–DSMB. She is a nonexecutive director of Renalytix AI. G.N. Nadkarni reports employment with, consultancy agreements with, and ownership interest in Pensieve Health and Renalytix AI; receiving consulting fees from AstraZeneca, BioVie, GLG Consulting, and Reata; and serving as a scientific advisor or member of Pensieve Health and Renalytix AI. G.N. Nadkarni is supported by a career development award from the National Institute of Diabetes and Digestive and Kidney Diseases (K23DK107908) and is also supported by R01DK108803, U01HG007278, U01HG009610, and U01DK116100. S. Somani reports consultancy agreements and ownership interest in Monogram Orthopedics. All remaining authors have nothing to disclose.

Funding

This study received support from National Institute of Diabetes and Digestive and Kidney Diseases grant K23DK107908.

Acknowledgments

We acknowledge all of the nurses, physicians, and providers who contributed to the care of these patients and all of the patients and their family members who were affected by this pandemic.

Supplemental Material

This article contains the following supplemental material online at http://cjasn.asnjournals.org/lookup/suppl/doi:10.2215/CJN.12360720/-/DCSupplemental.

Supplemental Summary 1. Collaborator information.

Footnotes

  • Published online ahead of print. Publication date available at www.cjasn.org.

  • Copyright © 2021 by the American Society of Nephrology

References

  1. ↵
    1. Xiong F,
    2. Tang H,
    3. Liu L,
    4. Tu C,
    5. Tian JB,
    6. Lei CT,
    7. Liu J,
    8. Dong JW,
    9. Chen WL,
    10. Wang XH,
    11. Luo D,
    12. Shi M,
    13. Miao XP,
    14. Zhang C
    : Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol 31: 1387–1397, 2020 10.1681/ASN.2020030354pmid:32385130
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Valeri AM,
    2. Robbins-Juarez SY,
    3. Stevens JS,
    4. Ahn W,
    5. Rao MK,
    6. Radhakrishnan J,
    7. Gharavi AG,
    8. Mohan S,
    9. Husain SA
    : Presentation and outcomes of patients with ESKD and COVID-19. J Am Soc Nephrol 31: 1409–1415, 2020 10.1681/ASN.2020040470pmid:32467113
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Ng JH,
    2. Hirsch JS,
    3. Wanchoo R,
    4. Sachdeva M,
    5. Sakhiya V,
    6. Hong S,
    7. Jhaveri KD,
    8. Fishbane S
    ; Northwell COVID-19 Research Consortium and the Northwell Nephrology COVID-19 Research Consortium: Outcomes of patients with end-stage kidney disease hospitalized with COVID-19 [published online ahead of print August 15, 2020]. Kidney Int 10.1016/j.kint.2020.07.030pmid:32810523
    OpenUrlCrossRefPubMed
  4. ↵
    1. Tortonese S,
    2. Scriabine I,
    3. Anjou L,
    4. Loens C,
    5. Michon A,
    6. Benabdelhak M,
    7. Ouali S,
    8. Morin G,
    9. Laifi M,
    10. Dobosziewicz H,
    11. Guillet M,
    12. Dekeyser M,
    13. Luong Nguyen LB,
    14. Grünenwald A,
    15. Dang J,
    16. Desbuissons G,
    17. Becquemont L,
    18. Snanoudj R,
    19. Legendre C,
    20. Hebibi H,
    21. Lefèvre E,
    22. Beaudreuil S,
    23. Zaidan M
    ; AP-HP/Universities/Inserm COVID-19 research collaboration: COVID-19 in patients on maintenance dialysis in the Paris region. Kidney Int Rep 5: 1535–1544, 2020 10.1016/j.ekir.2020.07.016pmid:32838082
    OpenUrlCrossRefPubMed
  5. ↵
    1. Apel M,
    2. Maia VP,
    3. Zeidan M,
    4. Schinkoethe C,
    5. Wolf G,
    6. Reinhart K,
    7. Sakr Y
    : End-stage renal disease and outcome in a surgical intensive care unit. Crit Care 17: R298, 2013 10.1186/cc13167pmid:24365096
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 16 (3)
Clinical Journal of the American Society of Nephrology
Vol. 16, Issue 3
March 08, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Outcomes of Patients on Maintenance Dialysis Hospitalized with COVID-19
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Outcomes of Patients on Maintenance Dialysis Hospitalized with COVID-19
Lili Chan, Suraj K. Jaladanki, Sulaiman Somani, Ishan Paranjpe, Arvind Kumar, Shan Zhao, Lewis Kaufman, Staci Leisman, Shuchita Sharma, John Cijiang He, Barbara Murphy, Zahi A. Fayad, Matthew A. Levin, Erwin P. Bottinger, Alexander W. Charney, Benjamin S. Glicksberg, Steven G. Coca, Girish N. Nadkarni, on behalf of the Mount Sinai COVID Informatics Center (MSCIC)
CJASN Mar 2021, 16 (3) 452-455; DOI: 10.2215/CJN.12360720

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Outcomes of Patients on Maintenance Dialysis Hospitalized with COVID-19
Lili Chan, Suraj K. Jaladanki, Sulaiman Somani, Ishan Paranjpe, Arvind Kumar, Shan Zhao, Lewis Kaufman, Staci Leisman, Shuchita Sharma, John Cijiang He, Barbara Murphy, Zahi A. Fayad, Matthew A. Levin, Erwin P. Bottinger, Alexander W. Charney, Benjamin S. Glicksberg, Steven G. Coca, Girish N. Nadkarni, on behalf of the Mount Sinai COVID Informatics Center (MSCIC)
CJASN Mar 2021, 16 (3) 452-455; DOI: 10.2215/CJN.12360720
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Funding
    • Acknowledgments
    • Supplemental Material
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Humoral Response to One and Two Doses of ChAdOx1-S Vaccine in Patients on Hemodialysis
  • Humoral Response to BNT162b2 mRNA SARS-CoV-2 Vaccine in Patients with Nondialysis Chronic Kidney Disease
  • Black Race Coefficient in GFR Estimation and Prevalence of CKD-Related Complications
Show more Research Letters

Cited By...

  • Racial and Neighborhood-Level Disparities in COVID-19 Incidence among Patients on Hemodialysis in New York City
  • Google Scholar

Similar Articles

Related Articles

  • PubMed
  • Google Scholar

Keywords

  • chronic dialysis
  • COVID-19
  • end-stage kidney disease

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire